Moumita Banerjee

Title: Innovations by Moumita Banerjee in Cancer Treatment

Introduction

Moumita Banerjee is an accomplished inventor based in Huntington, WV (US). She has made significant contributions to the field of medical research, particularly in the treatment and diagnosis of liver diseases. With a total of three patents to her name, her work focuses on innovative methods that address critical health issues.

Latest Patents

Moumita's latest patents include groundbreaking methods for the treatment and diagnosis of non-alcoholic steatohepatitis and hepatocellular carcinoma. One of her notable inventions involves administering a polypeptide antagonist of a Na/K ATPase/Src receptor complex to patients in need. This method not only aids in treatment but also provides assays for diagnosis or prognosis by analyzing biomarkers such as Caveolin-1, Survivin, and SMAC in biological samples. Additionally, she has developed methods for detecting Na/K-ATPase-mediated Src signaling, which are crucial for diagnosing cancer by measuring phosphorylation levels in biological samples. Her research also explores metabolic switches in cancer cells, further enhancing diagnostic capabilities.

Career Highlights

Moumita Banerjee is affiliated with the Marshall University Research Corporation, where she continues to advance her research. Her work has garnered attention for its potential impact on cancer treatment and diagnosis, showcasing her dedication to improving patient outcomes.

Collaborations

Moumita collaborates with esteemed colleagues, including Zijian Xie and Juan Sanabria, to further her research initiatives. These collaborations enhance the depth and breadth of her work, contributing to innovative solutions in the medical field.

Conclusion

Moumita Banerjee's contributions to medical research through her patents reflect her commitment to addressing significant health challenges. Her innovative methods for treating and diagnosing liver diseases position her as a leading figure in her field.